CIK: 1551246 - Address: C/O Opiant Pharmaceuticals, Inc., 233 Wilshire Blvd, Suite 400, Santa Monica, CA 90401
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/15/22 16:30
6/13/22
OPNTOpiant Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSinclair MichaelCADTS.m-14910.960-14-4119D
6/13/22 16:05
6/9/22
OPNTOpiant Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSinclair MichaelCADTS-9712.250-8-1933D
6/8/22 16:39
6/6/22
OPNTOpiant Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSinclair MichaelCADTS.m-11012.930-8-1741D
6/6/22 16:57
6/2/22
OPNTOpiant Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSinclair MichaelCADTS.m-27513.730-20-2949D
8/25/21 16:38
8/23/21
OPNTOpiant Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSinclair MichaelCADTM.dm7505.000150144D
8/25/21 16:38
8/23/21
OPNTOpiant Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSinclair MichaelCADTS.dm-2,35715.710-150-51144D
9/13/19 16:09
9/12/19
OPNTOpiant Pharmaceuticals, Inc.NVMiningIndMnMetal MiningSinclair MichaelCADTS-75112.520-60-4669D
1/17/17 21:26
1/17/17
OPNTOpiant Pharmaceuticals, Inc.NVMiningIndMnMetal MiningSinclair MichaelCADOTExec CBP257.01042160D
12/3/15 16:28
1/15/15
LLTPLightlake Therapeutics Inc.NVMiningIndMnMetal MiningSinclair MichaelNYDOTExec CBS.ad-63.500-2-1149D
11/6/15 06:00
1/15/15
LLTPLightlake Therapeutics Inc.NVMiningIndMnMetal MiningSinclair MichaelNYDOTExec CBS.d-63.500-2-1118M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact